1. Identification of a novel antiviral micro-RNA targeting the NS1 protein of the H1N1 pandemic human influenza virus and a corresponding viral escape mutation
- Author
-
Giulia Campanini, Silvia Bione, Antonella Lisa, Giovanni Maga, Laura Bavagnoli, Fausto Baldanti, Giorgia Ceccotti, Elena Percivalle, and Maurizio Forte
- Subjects
0301 basic medicine ,Genotype ,viruses ,030106 microbiology ,Biology ,Viral Nonstructural Proteins ,medicine.disease_cause ,Virus ,03 medical and health sciences ,Influenza A Virus, H1N1 Subtype ,Virology ,Cell Line, Tumor ,microRNA ,Influenza, Human ,Influenza A virus ,medicine ,Humans ,Gene ,3' Untranslated Regions ,Pharmacology ,Mutation ,Innate immune system ,Binding Sites ,Polymorphism, Genetic ,Gene Expression Profiling ,virus diseases ,Computational Biology ,MicroRNAs ,030104 developmental biology ,Viral replication ,Haplotypes ,Apoptosis ,Host-Pathogen Interactions ,RNA, Viral ,RNA Interference ,Seasons - Abstract
The influenza A virus (IAV) NS1 protein is one of the major regulators of pathogenicity, being able to suppress innate immune response and host protein synthesis. In this study we identified the human micro RNA hsa-miR-1307-3p as a novel potent suppressor of NS1 expression and influenza virus replication. Transcriptomic analysis indicates that hsa-miR-1307-3p also negatively regulates apoptosis and promotes cell proliferation. In addition, we identified a novel mutation in the NS1 gene of A(H1N1)pdm09 strains circulating in Italy in the 2010-11 season, which enabled the virus to escape the hsa-miR-1307-3p inhibition, conferring replicative advantage to the virus in human cells. To the best of our knowledge, this is the first validation of suppression of IAV H1N1 NS1 by a human micro RNA and the first example of an escape mutation from micro RNA-mediated antiviral response for the A(H1N1)pdm09 virus.
- Published
- 2019